298 related articles for article (PubMed ID: 29992403)
21. Theranostic pH-sensitive nanoparticles for highly efficient targeted delivery of doxorubicin for breast tumor treatment.
Pan C; Liu Y; Zhou M; Wang W; Shi M; Xing M; Liao W
Int J Nanomedicine; 2018; 13():1119-1137. PubMed ID: 29520140
[TBL] [Abstract][Full Text] [Related]
22. Oral Targeted Delivery by Nanoparticles Enhances Efficacy of an Hsp90 Inhibitor by Reducing Systemic Exposure in Murine Models of Colitis and Colitis-Associated Cancer.
Yang M; Zhang F; Yang C; Wang L; Sung J; Garg P; Zhang M; Merlin D
J Crohns Colitis; 2020 Jan; 14(1):130-141. PubMed ID: 31168612
[TBL] [Abstract][Full Text] [Related]
23. Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin.
Bae Y; Buresh RA; Williamson TP; Chen TH; Furgeson DY
J Control Release; 2007 Sep; 122(1):16-23. PubMed ID: 17651857
[TBL] [Abstract][Full Text] [Related]
24. Salvianolic acid B protects against myocardial damage caused by nanocarrier TiO
Ding L; Li J; Huang R; Liu Z; Li C; Yao S; Wang J; Qi D; Li N; Pi J
Int J Nanomedicine; 2016; 11():5709-5727. PubMed ID: 27843313
[TBL] [Abstract][Full Text] [Related]
25. Multifunctional mitoxantrone-conjugated magnetic nanosystem for targeted therapy of folate receptor-overexpressing malignant cells.
Barar J; Kafil V; Majd MH; Barzegari A; Khani S; Johari-Ahar M; Asgari D; Coukos G; Omidi Y
J Nanobiotechnology; 2015 Mar; 13():26. PubMed ID: 25880772
[TBL] [Abstract][Full Text] [Related]
26. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
27. Thermosensitive Betulinic Acid-Loaded Magnetoliposomes: A Promising Antitumor Potential for Highly Aggressive Human Breast Adenocarcinoma Cells Under Hyperthermic Conditions.
Farcas CG; Dehelean C; Pinzaru IA; Mioc M; Socoliuc V; Moaca EA; Avram S; Ghiulai R; Coricovac D; Pavel I; Alla PK; Cretu OM; Soica C; Loghin F
Int J Nanomedicine; 2020; 15():8175-8200. PubMed ID: 33122905
[TBL] [Abstract][Full Text] [Related]
28. Folate receptor-mediated celastrol and irinotecan combination delivery using liposomes for effective chemotherapy.
Soe ZC; Thapa RK; Ou W; Gautam M; Nguyen HT; Jin SG; Ku SK; Oh KT; Choi HG; Yong CS; Kim JO
Colloids Surf B Biointerfaces; 2018 Oct; 170():718-728. PubMed ID: 30005409
[TBL] [Abstract][Full Text] [Related]
29. Enhanced therapeutic efficacy of LHRHa-targeted brucea javanica oil liposomes for ovarian cancer.
Ye H; Liu X; Sun J; Zhu S; Zhu Y; Chang S
BMC Cancer; 2016 Oct; 16(1):831. PubMed ID: 27793127
[TBL] [Abstract][Full Text] [Related]
30. VIP-grafted sterically stabilized phospholipid nanomicellar 17-allylamino-17-demethoxy geldanamycin: a novel targeted nanomedicine for breast cancer.
Onyüksel H; Mohanty PS; Rubinstein I
Int J Pharm; 2009 Jan; 365(1-2):157-61. PubMed ID: 18793708
[TBL] [Abstract][Full Text] [Related]
31. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
Huang Y; Mao K; Zhang B; Zhao Y
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
[TBL] [Abstract][Full Text] [Related]
32. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
[TBL] [Abstract][Full Text] [Related]
33. IR780-loaded folate-targeted nanoparticles for near-infrared fluorescence image-guided surgery and photothermal therapy in ovarian cancer.
Song J; Zhang N; Zhang L; Yi H; Liu Y; Li Y; Li X; Wu M; Hao L; Yang Z; Wang Z
Int J Nanomedicine; 2019; 14():2757-2772. PubMed ID: 31118609
[No Abstract] [Full Text] [Related]
34. Dual-target recognition sandwich assay based on core-shell magnetic mesoporous silica nanoparticles for sensitive detection of breast cancer cells.
Wang W; Liu S; Li C; Wang Y; Yan C
Talanta; 2018 May; 182():306-313. PubMed ID: 29501157
[TBL] [Abstract][Full Text] [Related]
35. Image-guided photo-therapeutic nanoporphyrin synergized HSP90 inhibitor in patient-derived xenograft bladder cancer model.
Long Q; Lin TY; Huang Y; Li X; Ma AH; Zhang H; Carney R; Airhart S; Lam KS; deVere White RW; Pan CX; Li Y
Nanomedicine; 2018 Apr; 14(3):789-799. PubMed ID: 29317342
[TBL] [Abstract][Full Text] [Related]
36. Complex of TNF-α and Modified Fe
Teo P; Wang X; Chen B; Zhang H; Yang X; Huang Y; Tang J
Cancer Biother Radiopharm; 2017 Dec; 32(10):379-386. PubMed ID: 29265918
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
38. Heat-activated drug delivery increases tumor accumulation of synergistic chemotherapies.
Dunne M; Epp-Ducharme B; Sofias AM; Regenold M; Dubins DN; Allen C
J Control Release; 2019 Aug; 308():197-208. PubMed ID: 31195059
[TBL] [Abstract][Full Text] [Related]
39. Fe
Lu Q; Dai X; Zhang P; Tan X; Zhong Y; Yao C; Song M; Song G; Zhang Z; Peng G; Guo Z; Ge Y; Zhang K; Li Y
Int J Nanomedicine; 2018; 13():2491-2505. PubMed ID: 29719396
[TBL] [Abstract][Full Text] [Related]
40. Magnetically and pH dual responsive dendrosomes for tumor accumulation enhanced folate-targeted hybrid drug delivery.
Wang M; Li J; Li X; Mu H; Zhang X; Shi Y; Chu Y; Wang A; Wu Z; Sun K
J Control Release; 2016 Jun; 232():161-74. PubMed ID: 27090165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
